Alyeska Investment Group
ORKA

Alyeska Investment Group’s Oruka Therapeutics ORKA Stock Holding History

Alyeska Investment Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.35M Sell
87,744
-97,119
-53% -$6.47M 0.02% 453
2026
Q1 		$9.07M Buy
184,863
+84,863
+85% +$2.95M 0.03% 414
2025
Q4 		$3.03M Buy
+100,000
New +$2.79M 0.01% 495

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Alyeska Investment Group's ORKA Position: Q2 2026 in Review

Alyeska Investment Group reduced its Oruka Therapeutics (ORKA) stake by 53% in Q2 2026, selling an estimated $6.47M and leaving 87,744 shares worth $8.35M. The position accounts for 0.02% of the portfolio, ranked #453.

Alyeska Investment Group first reported a position in ORKA in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.07M in Q1 2026. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Alyeska Investment Group held 87,744 shares of Oruka Therapeutics worth $8.35M as of Q2 2026.
  • Alyeska Investment Group sold 97,119 Oruka Therapeutics shares in Q2 2026, an estimated $6.47M.
  • Oruka Therapeutics made up 0.02% of Alyeska Investment Group's portfolio in Q2 2026, its #453 holding.
  • Alyeska Investment Group first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Alyeska Investment Group's Oruka Therapeutics position peaked at $9.07M in Q1 2026.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.